Taro Pharmaceutical Industries Ltd. Gross Margin 2010-2023 | TARO
Current and historical gross margin for Taro Pharmaceutical Industries Ltd. (TARO) over the last 10 years. The current gross profit margin for Taro Pharmaceutical Industries Ltd. as of December 31, 2023 is %.
Gross Margin Historical Data |
Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
2023-12-31 |
$0.61B |
$0.29B |
48.12% |
2023-09-30 |
$0.59B |
$0.28B |
46.88% |
2023-06-30 |
$0.58B |
$0.25B |
43.65% |
2023-03-31 |
$0.57B |
$0.27B |
46.95% |
2022-12-31 |
$0.57B |
$0.27B |
47.45% |
2022-09-30 |
$0.57B |
$0.28B |
49.56% |
2022-06-30 |
$0.57B |
$0.30B |
52.01% |
2022-03-31 |
$0.56B |
$0.29B |
52.23% |
2021-12-31 |
$0.57B |
$0.29B |
51.77% |
2021-09-30 |
$0.57B |
$0.29B |
51.15% |
2021-06-30 |
$0.58B |
$0.31B |
53.63% |
2021-03-31 |
$0.55B |
$0.30B |
54.10% |
2020-12-31 |
$0.58B |
$0.32B |
55.90% |
2020-09-30 |
$0.58B |
$0.34B |
58.73% |
2020-06-30 |
$0.60B |
$0.36B |
60.30% |
2020-03-31 |
$0.65B |
$0.40B |
62.02% |
2019-12-31 |
$0.65B |
$0.42B |
64.31% |
2019-09-30 |
$0.68B |
$0.44B |
65.19% |
2019-06-30 |
$0.68B |
$0.45B |
66.42% |
2019-03-31 |
$0.67B |
$0.45B |
66.72% |
2018-12-31 |
$0.67B |
$0.45B |
67.07% |
2018-09-30 |
$0.64B |
$0.43B |
66.93% |
2018-06-30 |
$0.66B |
$0.45B |
68.24% |
2018-03-31 |
$0.66B |
$0.46B |
70.20% |
2017-12-31 |
$0.68B |
$0.49B |
71.70% |
2017-09-30 |
$0.75B |
$0.55B |
74.03% |
2017-06-30 |
$0.81B |
$0.61B |
75.06% |
2017-03-31 |
$0.88B |
$0.67B |
76.34% |
2016-12-31 |
$0.95B |
$0.75B |
79.22% |
2016-09-30 |
$0.99B |
$0.80B |
80.93% |
2016-06-30 |
$0.97B |
$0.79B |
81.53% |
2016-03-31 |
$0.95B |
$0.78B |
82.00% |
2015-12-31 |
$0.93B |
$0.76B |
81.27% |
2015-09-30 |
$0.91B |
$0.74B |
80.86% |
2015-06-30 |
$0.95B |
$0.76B |
80.59% |
2015-03-31 |
$0.86B |
$0.68B |
78.45% |
2014-12-31 |
$0.81B |
$0.62B |
76.67% |
2014-09-30 |
$0.78B |
$0.60B |
76.21% |
2014-06-30 |
$0.74B |
$0.56B |
75.68% |
2014-03-31 |
$0.76B |
$0.58B |
76.28% |
2013-12-31 |
$0.74B |
$0.56B |
75.58% |
2013-09-30 |
$0.71B |
$0.53B |
74.05% |
2013-06-30 |
$0.67B |
$0.49B |
73.23% |
2013-03-31 |
$0.67B |
$0.49B |
73.62% |
2012-12-31 |
$0.65B |
$0.47B |
72.81% |
2012-09-30 |
$0.61B |
$0.44B |
71.78% |
2012-06-30 |
$0.59B |
$0.41B |
69.83% |
2012-03-31 |
$0.54B |
$0.37B |
67.22% |
2011-12-31 |
$0.51B |
$0.33B |
65.02% |
2011-09-30 |
$0.46B |
$0.28B |
61.30% |
2011-06-30 |
$0.43B |
$0.25B |
58.82% |
2011-03-31 |
$0.41B |
$0.24B |
58.39% |
2010-12-31 |
$0.39B |
$0.23B |
58.16% |
2010-09-30 |
$0.38B |
$0.22B |
58.40% |
2010-06-30 |
$0.37B |
$0.21B |
57.10% |
2010-03-31 |
$0.37B |
$0.21B |
57.53% |